EP2306 and EP2302, two novel squalene synthase inhibitors, stimulate endothelial nitric oxide synthase expression in cultured endothelial cells.

about

Regulation and deregulation of cholesterol homeostasis: The liver as a metabolic "power station".

P2860

Q36071668-614740B3-7694-4B73-9E1C-3DC3B60F46D0

P2860

EP2306 and EP2302, two novel squalene synthase inhibitors, stimulate endothelial nitric oxide synthase expression in cultured endothelial cells.

Item

http://www.wikidata.org/entity/Q42519931

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年学术文章

@wuu

2007年学术文章

@zh-cn

2007年学术文章

@zh-hans

2007年学术文章

@zh-my

2007年学术文章

@zh-sg

2007年學術文章

@yue

2007年學術文章

@zh

2007年學術文章

@zh-hant

name

EP2306 and EP2302, two novel s ...... in cultured endothelial cells.

@en

EP2306 and EP2302, two novel s ...... in cultured endothelial cells.

@nl

type

Item

label

EP2306 and EP2302, two novel s ...... in cultured endothelial cells.

@en

EP2306 and EP2302, two novel s ...... in cultured endothelial cells.

@nl

prefLabel

EP2306 and EP2302, two novel s ...... in cultured endothelial cells.

@en

EP2306 and EP2302, two novel s ...... in cultured endothelial cells.

@nl

P1476

EP2306 and EP2302, two novel s ...... in cultured endothelial cells.

@en

P2093

Angeliki P Kourounakis

http://www.w3.org/2001/XMLSchema#string

Anna Tavridou

http://www.w3.org/2001/XMLSchema#string

Avgui Charalambous

http://www.w3.org/2001/XMLSchema#string

George Megaritis

http://www.w3.org/2001/XMLSchema#string

Vangelis G Manolopoulos

http://www.w3.org/2001/XMLSchema#string

P2860

Direct interaction of endothelial nitric-oxide synthase and caveolin-1 inhibits synthase activity

Dysfunction of endothelial nitric oxide synthase and atherosclerosis

Squalene synthase inhibitors : clinical pharmacology and cholesterol-lowering potential

Endothelial nitric oxide synthase is regulated by tyrosine phosphorylation and interacts with caveolin-1

Effects of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors, atorvastatin and simvastatin, on the expression of endothelin-1 and endothelial nitric oxide synthase in vascular endothelial cells

Endothelial nitric oxide synthase targeting to caveolae. Specific interactions with caveolin isoforms in cardiac myocytes and endothelial cells

Antiatherosclerotic activity of drugs in relation to nitric oxide function.

Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors.

Lipid-lowering properties of TAK-475, a squalene synthase inhibitor, in vivo and in vitro.

3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors protect against oxidized low-density lipoprotein-induced endothelial dysfunction.

P304

239-243

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/10623320701547216

http://www.w3.org/2001/XMLSchema#string

P433

4-5

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2007-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5923410

http://www.w3.org/2001/XMLSchema#string

P698

17922341

http://www.w3.org/2001/XMLSchema#string

P921

endothelium

EP2306 and EP2302, two novel squalene synthase inhibitors, stimulate endothelial nitric oxide synthase expression in cultured endothelial cells.

about

P2860

P2860

EP2306 and EP2302, two novel squalene synthase inhibitors, stimulate endothelial nitric oxide synthase expression in cultured endothelial cells.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P921